CHINA MEDICAL UNIVERSITY
Clinical Trials
85
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (74 trials with phase data)• Click on a phase to view related trials
A Study Evaluating the Efficacy of PD-1 Inhibitor Combined With Denosumab and Chemotherapy in Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Patients With Driver Gene-Negative Status
- Conditions
- Non-Small Cell Lung Cancer
- Interventions
- Drug: denosumab combined anti-PD-1 inhibitor with chemotherapy
- First Posted Date
- 2025-06-24
- Last Posted Date
- 2025-06-24
- Lead Sponsor
- China Medical University, China
- Target Recruit Count
- 40
- Registration Number
- NCT07034391
- Locations
- 🇨🇳
The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China
The Effect of Situation Puzzle Games on Nursing Students' Death Anxiety and Meaning in Life
- Conditions
- Death Anxiety
- First Posted Date
- 2025-05-28
- Last Posted Date
- 2025-05-28
- Lead Sponsor
- China Medical University, China
- Target Recruit Count
- 70
- Registration Number
- NCT06991621
- Locations
- 🇨🇳
School of Nursing, China Medical University, Shenyang, Liaoning, China
Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line Induction
- Conditions
- Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2025-04-30
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- China Medical University, China
- Target Recruit Count
- 31
- Registration Number
- NCT06951841
- Locations
- 🇨🇳
The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China
Establishment of Precision Targeted Therapy Strategies for Advanced Gastric Cancer Based on Novel Molecular Subtyping
- Conditions
- Gastric CancerHER2 + Gastric CancerPD-L1 PositiveCLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction
- Interventions
- First Posted Date
- 2025-03-18
- Last Posted Date
- 2025-03-18
- Lead Sponsor
- China Medical University, China
- Target Recruit Count
- 140
- Registration Number
- NCT06881017
Effects of Different Occlusion Angles of Disposable Tracheal Blocker on Right One-lung Ventilation
- Conditions
- The Direction of Blocker Placement
- First Posted Date
- 2024-09-13
- Last Posted Date
- 2024-09-16
- Lead Sponsor
- China Medical University, China
- Target Recruit Count
- 96
- Registration Number
- NCT06595043
- Locations
- 🇨🇳
Wenfei Tan, Shenyang, China
🇰🇷Konkuk University School of Medicine, Seoul, Korea, Republic of
🇷🇸the University Clinical Center of Serbia, Belgrade, Serbia
- Prev
- 1
- 2
- 3
- 4
- 5
- 17
- Next
News
China Medical University Achieves Milestone with CAR001 Cell Therapy for Solid Tumors
China Medical University (CMU) and Healthcare System secured 17 awards at the Taiwan National Innovation Awards, recognizing breakthroughs in biotechnology and smart healthcare.
Sacituzumab Tirumotecan Demonstrates Antitumor Activity in Advanced Endometrial and Ovarian Cancers
Sacituzumab tirumotecan (sac-TMT) monotherapy shows promising antitumor activity in patients with previously treated advanced endometrial cancer, with an objective response rate (ORR) of 34.1%.